Abstract:
The present invention aims to provide a method and an apparatus for producing a lyophilized body, each of which can achieve energy saving, low cost, and a reduction in processing time and can provide a lyophilized body less damaged by a freezing process and a drying process. The present invention relates to a method for lyophilizing a substance using an electromagnetic wave, and the lyophilization method includes freezing the substance under irradiation of at least an electromagnetic wave and reduced-pressure drying the frozen substance under irradiation of at least an electromagnetic wave.
Abstract:
Provided is a transdermal absorption preparation having superior drug skin permeability, which can uniformly disperse the drug in the preparation and maintain the uniform dispersion state of the drug.A transdermal absorption preparation having a plaster layer containing a drug, a polymer and a pH adjuster, in which the aforementioned polymer contains a polymer having a particular glass transition temperature of 30° C.-200° C., and the surface of the plaster layer has a pH of 6.7-10.0.
Abstract:
Provided are a surface protection sheet with excellent weatherability, good anti-residue properties and low-contaminating properties and a water-dispersed PSA composition for surface protection sheets. The surface protection sheet provided by this invention comprises a PSA layer and a support substrate. The PSA layer is formed from a water-dispersed PSA composition comprising an acrylic polymer and a crosslinking agent. The acrylic polymer is obtained by emulsion polymerization of a starting monomer mixture comprising 50 to 99.9 wt % C1-20alkyl (meth)acrylate and 0.1 to 5 wt. % carboxy group-containing monomer. The crosslinking agent comprises one, two or more species selected from a group consisting of oxazoline-based crosslinking agents, isocyanate-based crosslinking agents and epoxy-based crosslinking agents. The support substrate comprises 50% by weight or more polyolefin resin and 5 to 30% by weight inorganic powder.
Abstract:
Provided are a production method of a pregabalin-containing composition, which suppresses crystallization of pregabalin, and a pregabalin-containing composition that shows suppressed crystallization of Pregabalin. The production method of the pregabalin-containing composition of the present invention contains steps of:(1) dissolving pregabalin in an aqueous solution of an acid to prepare an aqueous solution of a salt of pregabalin; (2) mixing the aqueous solution of pregabalin salt and a hydrophilic resin to prepare a mixture thereof; and (3) concentrating the mixture; wherein the acid has an acid dissociation constant lower than that of pregabalin.
Abstract:
Provided is a transdermal absorption preparation that shows superior skin permeability of a drug and that does not easily cause cold flow.A transdermal absorption preparation having a drug-containing layer containing a drug and a polymer, wherein 50-100 wt % of the polymer in the drug-containing layer is a polymer having a glass transition temperature of 30° C.-200° C., and the drug in the drug-containing layer is in an amorphous state.
Abstract:
This invention provides a surface protection sheet that allows for easy application to an adherend surface with good removability. The surface protection sheet provided by this invention comprises a PSA layer and a support substrate supporting the PSA layer. The surface protection sheet has a peel strength (SA) after adhered to a stainless steel plate and stored at 23° C. for 30 minutes, and a peel strength (SB) after adhered on a stainless steel plate and stored at 70° C. for 168 hours, at a peel strength ratio (SB/SA) of 5 or less. The surface protection sheet has a peel strength to itself of 5 N/25 mm or less when the PSA layer is adhered to itself and peeled apart after one minute.